Frans Trouwen Email & Phone Number

Heemstede, Nh, Nl

Heemstede, Nl

Heemstede, Nl

Ever since the end of 2012 Frans is the owner of the Liberi Group of Companies and works as a consultant/business development advisor again in the Life Science Industry through Liberi Life Science Consultancy B.V. (over 425 Pharma companies and over 245 Investment Groups are part of our global network) Through this venture Frans is active in the area of bridging demand and supply as a senior business development advisor and manager. More specific the activities of Liberi Life Science Consultancy consist of: • Identification and evaluation of product opportunities/alliance opportunities at (European) universities, • Structure, negotiate and close private equity investments or co-development deals with Pharma companies, • Preparation/revision of business plans, presentations, and corporate communication materials, • Identification of new and value-adding life science technologies/products for corporate clients, • Identification, mediation and negotiation of client licensing, merger or acquisition transactions, • Advise clients on management, focus, and structure of life science New Co’s, • Sourcing of investment capital in The Netherlands but especially global, • Life Sciences Investment Advisory Services, • Representation on Board of Directors of invested companies, • Ongoing business management, consultation, strategic planning, • Targeting and negotiating New Co strategic alliances.In addition to this, Frans maintains a network and experience in both Biotech, Pharma, Investment as well as Food, Feed and Nutrition.

Trading Wines for Return

Heemstede, Nh, Nl

Matrimonio Group was active in the consultancy for legal and financial affairs of professionals for (local) governments.

The Company was founded in 2002 as a spin-out from the Academic Medical Center (AMC), University of Amsterdam. The Company is active in the field of anti-inflammatory topical dermatology and focuses its research and development on innovative compounds for several topical applications. The current pipeline consists out of two compounds under patent protection: imidazole-4-carboxylic acid (ImCOOH) and ethyl imidazole-4-acetate (Et-ImAc). Several other compounds and applications can be developed, all covered by world-wide patents and patent applications. The Company is structured as a Holding Company with two fully-owned research subsidiaries and two-fully owned Intellectual Property companies. New, innovative product line for anti-inflammatory, topical formulations, low COG, low side-effect spectrum, from natural origin or synthetic derivatives.Valletta Health BV has finalized its atopic eczema Phase 2A patient study in Malaga (Spain). The results of the Patient Study showed statistically significant results in atopic eczema patients with no adverse side effects. Valletta also finalised a small Phase 2A study in Malaga for acne. This study showed efficacy as well.

Amstelveen, Nl

Rotterdam, Zuid-Holland, Nl

Den Haag, Zuid-Holland, Nl

Drs., Bedrijfskunde

Register Bedrijfskundige, Bedrijfskunde